Vanderbilt Lung Screening Program

 

 

If you are a patient interested in learning more about lung screening, you can learn more here

The Vanderbilt Lung Screening Program is a comprehensive program that offers annual lung screening CT and management by a Radiology NP who performs a shared decision making visit with the patient, offers tobacco cessation counseling, informs patients and referring providers of CT results, assists with referrals to specialists, tracks patients for follow-up compliance, and sends reminders to patients for annual follow-up screenings.

As part of an overall health plan, lung screening is an effective detection tool for patients at elevated risk for lung cancer. Lung screening uses low-dose computed tomography (LDCT) resulting in either positive or negative signs of lung cancer. Early detection is one of the most powerful tools to reduce the risk of lung cancer death while negative results can give your patient peace of mind, aiding their overall health.

Using ACR-accredited imaging facilities, the Vanderbilt Lung Screening Program has performed nearly 2,000 lung screening tests since 2013. Our team of highly trained radiologists, nurse practitioners, and technologists will provide your patient with the best possible care.

Contact Us:

Appointments

Phone: (615) 936-3606
Fax: (615) 936-5343

Vanderbilt Lung Screening Clinical Questions

(615) 322-0580

 

Click image below to download our brochure. 

1667-5545-VH-Radiology-LungScreening-BR-DP (Digital)[2]_Page_1.jpg

Vanderbilt Lung Cancer Screening Center

 

 

Learn More:

CT for lung screening is recommended for patients who meet high-risk for lung cancer criteria. The current criteria are:

  • Ages 55 to 80
  • Current or former smokers with 30 or more pack year history who have smoked in the past 15 years

Screening can detect lung cancer before symptoms develop and the disease spreads. Early detection of lung cancer by annual LDCT has been shown to reduce lung cancer mortality by 20 percent in this high-risk population.

Patients who meet high risk for lung cancer criteria should be screened annually from 55 to 80 years old.

Shared Decision Making Visit

Medicare and private insurance companies require that a patient meet with a provider prior to their CT for lung screening to confirm the patient’s smoking history and that specific risks and benefits of the test are discussed in detail with the patient. Providers may choose to provide the Shared Decision Making Consultation themselves. If you wish to do so, please email Alexis Paulson for further instructions. Otherwise, the Radiology Nurse Practitioner provides this service on the day of the imaging test. In addition to the mandated topics of the visit, tobacco cessation counseling is provided

Additional Resources:

U.S. Preventive Services Task Force

American Cancer Society

National Comprehensive Cancer Network

American College of Radiology 

The American Association for Thoracic Surgery 

 

Vanderbilt providers may refer to our program through eStar by searching in the Medications & Orders field for ”lung cancer screening” or any combination of these words. This new orderable sets the patient up for their required Shared Decision Making Consult with our NP*, which is completed on the same day and location as the CT.

In the “Performing Department” field, list either OHO, Hillsboro, or Cool Springs. This will route the order directly to the correct scheduling queue for our outpatient locations. Please note, lung screenings are not performed at VUH.

We encourage providers to use Z87.981 (personal history of tobacco use) as the diagnosis for lung screening as it is accepted by Medicare and most private insurances without difficulty.

Once a patient has been referred they will be enrolled in our program, and we will order all future annual follow-up screenings within current CMS/USPSTF recommendations. Abnormalities on screening exams and recommendations will be communicated, and any diagnostic follow-up exam orders and/or referrals to pulmonology will be requested from referring providers. We are able to navigate patients to the Vanderbilt Lung Nodule Clinic, if requested, and appointments are typically available within five business days.

*Providers may choose to provide the Shared Decision Making Consultation themselves. If you wish to do so, please email Alexis Paulson for further instructions.

Vanderbilt Lung Screening Locations

Vanderbilt One Hundred Oaks Imaging
719 Thompson Lane, Suite 23300
Nashville, TN 37204
Vanderbilt Hillsboro Imaging
1909 Acklen Avenue
Nashville, TN 37212

Vanderbilt Cool Springs Imaging
2009 Mallory Lane, Suite 150
Franklin, TN 37067

Clinical Trials

Vanderbilt-Ingram Cancer Center also offers a clinical study for lung cancer screening at no cost for eligible patients. Learn more about the trial here.

How does it work?

During the appointment your patient will meet with a nurse practitioner to discuss their risk factors and the risks and benefits of the screening. Low-dose screening CT is performed without contrast and imaging acquisition takes less than five minutes. 

How does a patient prepare for the test?

There are no special instructions for your patients to follow prior or after the screening. 

How much does it cost?

If your patient qualifies as high-risk for lung cancer (which will be verified on the day of your visit), private insurance and Medicare should cover their screening in full.

Is it safe?

Radiation exposure from a low-dose CT for lung screening is equivalent to or less than the amount of radiation that one is naturally exposed to every 6-12 months. The most common negative effect is a false positive test.

 

If the results are normal, a nurse practitioner or radiologist will call your patient to discuss the results. Their results will also be available on My Health at Vanderbilt, our secure online health tool, and we will send them a letter with the results.

If there is an abnormality, the radiologist will call the referring provider to discuss referral or follow-up recommendations. 

Lung Nodule Clinic

Our Lung Nodule Clinic is available for all positive screening tests and offers the following services:

  • Evaluation of lung nodules
  • Evaluation of suspected lung cancer
  • Minimally invasive lung cancer staging
  • Evaluation of enlarged lymph nodes in chest (lymphadenopathy)
  • Bronchoscopy 
  • Computer assisted navigational biopsy of lung nodules. 
  • Linear and radial endobronchial ultrasound 
  • Smoking cessation counseling and treatment
  • Risk assessment and counseling for lung cancer screening 

 

Jeff Carr, M.D.John Carr, M.D.
Professor of Radiology and Radiological Sciences
Professor of Cardiovascular Medicine
Professor of Biomedical Informatics
Cornelius Vanderbilt Chair in Radiology & Radiological Sciences, Vice Chair of Informatics, Department of Radiology

 

Adam Guttentag, M.D.Adam Guttentag, M.D.
Associate Professor of Radiology and Radiological Sciences
 

 


Wiiiam Laxton, M.D.William Laxton, M.D.
Assistant Professor of Clinical Radiology and Radiological Sciences

 

 

 

Alexis Paulson, M.S.NAlexis Paulson, MSN, APRN, WHNP-BC, TTS
Radiology Nurse Practitioner, Tobacco Treatment Specialist
Clinical Coordinator, Vanderbilt Lung Screening Program

 

 

Otis Rickman, D.O.Otis Rickman, D.O.
Associate Professor of Medicine & Thoracic Surgery
Director of Bronchoscopy, Co-Director of Vanderbilt Lung Screening Program

 


Kim Sandler, M.D.Kim Sandler, M.D.
Assistant Professor of Radiology & Radiological Sciences
Co-Director of Vanderbilt Lung Screening Program

 

 

Brent Savoie, J.D., M.D.

Brent Savoie, M.D., J.D.
Assistant Professor in Clinical Radiology & Radiological Sciences
Section Chief, Cardiothoracic Imaging

 

 

Charla Walston, M.S.N.Charla Walston, M.S.N., AGACNP-BC
Interventional Pulmonology

 

 

 

John Worrell, M.D.John Worrell, M.D.
Professor Emeritus of Radiology & Radiological Sciences